These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8913714)

  • 1. Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.
    Vahanian A; Lung B
    Drugs; 1996; 52 Suppl 4():9-15; discussion 15-6. PubMed ID: 8913714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA.
    Chouairi S; Carrie D; Puel J
    Eur Heart J; 1995 Aug; 16 Suppl H():3-8. PubMed ID: 8846802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty.
    Schlant RC; King SB
    Circulation; 1989 Dec; 80(6 Suppl):IV88-92. PubMed ID: 2688988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
    Kocurek A; Piwowarska W
    Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.
    Parisi AF; Folland ED; Hartigan P
    N Engl J Med; 1992 Jan; 326(1):10-6. PubMed ID: 1345754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of silent ischemia].
    Mlczoch J
    Acta Med Austriaca; 1992; 19(3):70-3. PubMed ID: 1357905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results and clinical implications of the CAPARES trial.
    Thaulow E; Jorgensen B
    Can J Cardiol; 2000 Jul; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of calcium antagonists after PTCA.
    Hoberg E
    Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial stunning following coronary angioplasty: protective effects of calcium-channel blockers.
    Sheiban I; Tonni S; Benussi P; Marini A; Montresor G; Trevi GP
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S18-24. PubMed ID: 1282609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protection against ischemic damage during percutaneous coronary angioplasty].
    Specchia G; Ghio S; Bramucci E; Angoli L; Raffaghello S; De Servi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):215-20. PubMed ID: 1688158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of restenosis after PTCA: role of calcium antagonists.
    Hoberg E; Kübler W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S15-9. PubMed ID: 1725911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.
    Hillegass WB; Ohman EM; Leimberger JD; Califf RM
    Am J Cardiol; 1994 May; 73(12):835-9. PubMed ID: 8184803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
    Kern MJ
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevention and treatment for restenosis in coronary angioplasty].
    Degawa T; Yamaguchi T
    Nihon Rinsho; 1998 Oct; 56(10):2640-4. PubMed ID: 9796332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-PTCA detection of chronic but reversible postischemic myocardial dysfunction by nicardipine.
    Pust B; Surlan M
    Angiology; 1998 Feb; 49(2):115-27. PubMed ID: 9482511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.